 | |
| Founded | 1998 |
|---|---|
| Location |
|
Area served | Europe |
Key people | Prof. Angelica Lindén Hirschberg, President; Prof. Margaret Rees, Executive Director; Prof. Irene Lambrinoudaki, Scientific Director |
| Website | emas-online |
The European Menopause and Andropause Society is an institution that promotes the study, and encourages research of midlife health. Founded in 1998.
The official journal of EMAS, Maturitas, is published on a monthly basis by Elsevier Science It covers a variety of disciplines, including management of chronic diseases, epidemiology, therapeutic techniques, and alternative medicine. The journal impact factor is 5.110. [1] Irene Lambrinoudaki and Leon Flicker are the Editors-in-Chief. [2] EMAS is now affiliated with Case Reports in Women's Health, also published by Elsevier. The Editor-in-Chief is Margaret Rees.
EMAS participates in a variety of medical congresses related to menopause, gynecology, and obstetrics each year. The society hosts its own European Congress [3] every two years. EMAS also organises educational schools on menopausal health.
EMAS provides online education on its website with the textbook EMAS Care Online 2020 accompanied by PowerPoint presentations.
The aim of the mentorship programme, JuMP, is to encourage career development of junior clinicians and researchers in the field of post-reproductive health by pairing one expert mentor with a mentee, based on mutual research interests. The last round, 2021 – 2023, is completed.
The 12th European Congress on Menopause and Andropause was held in Berlin, in May 2019.
The 13th EMAS Congress took place virtually 8-10 September 2021 starting on 7 September with the launch of the first-ever World Menopause & Work Day.
Menopause, also known as the climacteric, is the time when menstrual periods permanently stop, marking the end of reproduction. It typically occurs between the ages of 45 and 55, although the exact timing can vary. Menopause is usually a natural change. It can occur earlier in those who smoke tobacco. Other causes include surgery that removes both ovaries or some types of chemotherapy. At the physiological level, menopause happens because of a decrease in the ovaries' production of the hormones estrogen and progesterone. While typically not needed, a diagnosis of menopause can be confirmed by measuring hormone levels in the blood or urine. Menopause is the opposite of menarche, the time when a girl's periods start.
Hormone therapy or hormonal therapy is the use of hormones in medical treatment. Treatment with hormone antagonists may also be referred to as hormonal therapy or antihormone therapy. The most general classes of hormone therapy are oncologic hormone therapy, hormone replacement therapy, androgen replacement therapy (ART), oral contraceptive pills, and transgender hormone therapy.
Actaea racemosa, the black cohosh, black bugbane, black snakeroot, rattle-top, or fairy candle, is a species of flowering plant of the family Ranunculaceae. It is native to eastern North America from the extreme south of Ontario to central Georgia, and west to Missouri and Arkansas. It grows in a variety of woodland habitats, and is often found in small woodland openings. The roots and rhizomes were used in traditional medicine by Native Americans. Its extracts are manufactured as herbal medicines or dietary supplements. Most dietary supplements containing black cohosh are not well-studied or recommended for safe and effective use in treating menopause symptoms or any disease. In contrast, some herbal medicinal products containing black cohosh extract hold a marketing authorization in several states of the European Union and are well-studied and recommended for safe and effective use for the relief of menopausal symptoms such as hot flushes and profuse sweating attacks. Such differentiation between the product types seems to be important.
Elsevier is a Dutch academic publishing company specializing in scientific, technical, and medical content. Its products include journals such as The Lancet, Cell, the ScienceDirect collection of electronic journals, Trends, the Current Opinion series, the online citation database Scopus, the SciVal tool for measuring research performance, the ClinicalKey search engine for clinicians, and the ClinicalPath evidence-based cancer care service. Elsevier's products and services include digital tools for data management, instruction, research analytics, and assessment.
Bioidentical hormone replacement therapy (BHRT), also known as bioidentical hormone therapy (BHT) or natural hormone therapy, is the use of hormones that are identical on a molecular level with endogenous hormones in hormone replacement therapy. It may also be combined with blood and saliva testing of hormone levels, and the use of pharmacy compounding to obtain hormones in an effort to reach a targeted level of hormones in the body. A number of claims by some proponents of BHT have not been confirmed through scientific testing. Specific hormones used in BHT include estrone, estradiol, progesterone, testosterone, dehydroepiandrosterone (DHEA), and estriol.
Late-onset hypogonadism (LOH) or testosterone deficiency syndrome (TDS) is a condition in older men characterized by measurably low testosterone levels and clinical symptoms mostly of a sexual nature, including decreased desire for mating, fewer spontaneous erections, and erectile dysfunction. It is the result of a gradual drop in testosterone; a steady decline in testosterone levels of about 1% per year can happen and is well documented in both men and women.
Estradiol acetate (EA), sold under the brand names Femtrace, Femring, and Menoring, is an estrogen medication which is used in hormone therapy for the treatment of menopausal symptoms in women. It is taken by mouth once daily or given as a vaginal ring once every three months.
PLOS Medicine is a peer-reviewed weekly medical journal covering the full spectrum of the medical sciences. It began operation on October 19, 2004, as the second journal of the Public Library of Science (PLOS), a non-profit open access publisher. All content in PLOS Medicine is published under the Creative Commons "by-attribution" license. To fund the journal, the publication's business model requires in most cases that authors pay publication fees. The journal was published online and in a printed format until 2005 and is now only published online. The journal's acting chief editor is Clare Stone, who replaced the previous chief editor, Larry Peiperl, in 2018.
Tibolone, sold under the brand name Livial among others, is a medication which is used in menopausal hormone therapy and in the treatment of postmenopausal osteoporosis and endometriosis. The medication is available alone and is not formulated or used in combination with other medications. It is taken by mouth.
Hormone replacement therapy (HRT), also known as menopausal hormone therapy or postmenopausal hormone therapy, is a form of hormone therapy used to treat symptoms associated with female menopause. Effects of menopause can include symptoms such as hot flashes, accelerated skin aging, vaginal dryness, decreased muscle mass, and complications such as osteoporosis, sexual dysfunction, and vaginal atrophy. They are mostly caused by low levels of female sex hormones that occur during menopause.
Robert Tan is a physician, author and medical director. He has written and lectured extensively on aging and men's health issues including andropause. He is a pioneer in testosterone replacement therapy and effects on the brain. Dr. Tan was in UK to complete his studies in Geriatric Medicine at the Royal Postgraduate Medical School, Hammersmith Hospital. His further medical training was completed at Case Western Reserve University in Cleveland, Ohio. He is noted to be one of the rare physicians in the world to hold multiple board certifications in different countries, and also an MBA. He is still in active clinical practice with more than 25 years experience and also founded the OPAL Medical Clinic, a unique center dedicated to wellness and men's health. He is Clinical Professor with University of Texas Houston & Associate Professor with Baylor College of Medicine and a board member of Men's Health Network. He has been elected to the Best Doctors in America for several consecutive years.
The Journal of Sexual Medicine (JSM) is a peer-reviewed medical journal published on behalf of the International Society for Sexual Medicine. Besides the latter society, it is also an official journal for the International Society for the Study of Women's Sexual Health. The editor-in-chief is John P. Mulhall. The related open access journal, Sexual Medicine, was launched in 2013.
The American Journal of Transplantation is a monthly peer-reviewed medical journal published by Elsevier on behalf of the American Society of Transplant Surgeons and the American Society of Transplantation. It covers research on all aspects of organ transplantation. Each issue offers continuing medical education in the form of its Images in Transplantation feature, a case-based approach.
The North American Menopause Society (NAMS), founded in 1989, is a nonprofit, multidisciplinary organization with the mission of promoting the health and quality of life of women during midlife and beyond through an understanding of menopause and healthy aging. Based in Cleveland, Ohio, NAMS has more than 2,800 members from 51 countries, with 88% of its members from North America.Its membership includes experts from many disciplines such as medicine, nursing, sociology, psychology, nutrition, anthropology, epidemiology, pharmacy, and education.
The Archives of Physical Medicine and Rehabilitation is the official journal of the American Congress of Rehabilitation Medicine (ACRM). The journal is published monthly by Elsevier and is the most highly cited journal in the Rehabilitation category of the Thomson Reuters Journal Citation Reports. The 2018 Impact Factor was 2.697.
The International Menopause Society (IMS) is a UK based charity. The Association was created in 1978 in Jerusalem during the second Menopause Congress and currently has members in 62 countries. In addition to organizing congresses, symposia, and workshops, the IMS owns its own journal: Climacteric, the Journal of Adult Women's Health and Medicine, published by Taylor & Francis.
Wulf H. Utian is a physician, reproductive endocrinologist, clinical researcher, and academic women's health department administrator. He is best known for first recognizing menopause as a potential health-related issue. He is the co-founder of the International Menopause Society and founder of the North American Menopause Society. Previously he has worked as a medical department Director at the Mount Sinai Medical Center, the University Hospitals of Cleveland, and academic chairman of the department of Reproductive Biology at Case Western Reserve University School of Medicine. He is currently the Arthur H. Bill Professor Emeritus of Reproductive Biology at the Case Western Reserve University School of Medicine, a consultant in women's health, and Scientific Director Emeritus of Rapid Medical Research Inc.
Maturitas is a monthly peer-reviewed medical journal covering midlife and post-reproductive health. It was established in 1978 and is the official journal of the European Menopause and Andropause Society; it is also affiliated with the Australasian Menopause Society. It is published by Elsevier and the editors-in-chief are Irene Lambrinoudaki and Leon Flicker. According to the Journal Citation Reports, the journal has a 2020 impact factor of 4.342.
Alastair Harvey MacLennan,, MB ChB, MD, FRCOG, FRANZCOG is a Scottish-Australian physician, professor of obstetrics and gynaecology, medical researcher, and a community health advocate. He studied and practised medicine in Glasgow, Chicago, and Oxford before moving to Australia in 1977 to take up a position at the University of Adelaide, where he went on to become the Professor and Head of the Discipline of Obstetrics and Gynaecology in 2006. He retired from his full-time academic position in 2013, and he is now Emeritus Professor of Medicine. He leads research projects at the Robinson Research Institute, and he is Head of the university's Cerebral Palsy Research Group.
Menopause in the workplace is a social and human resources campaigning issue in which people work to raise awareness of the impact menopause symptoms can have on attendance and performance in the workplace.
| International | |
|---|---|
| National | |
